Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Eight Pivotal Trial Read-Outs Expected In Q3

Jul 17 2018

• By Alexandra Shimmings

Pipes — Coming through the pipeline

Related Content

Zealand Rushes Out Good Safety News On Phase III Dasiglucagon Rescue Pen

Mar 21 2018

Just The Tonix: New York Biotech Has Breakthrough Drug For PTSD

Dec 22 2016

Valeant invests in EyeGate uveitis drug

Jul 10 2015

Aimmune Accelerates Commercial Planning For Peanut Allergy Drug

Feb 21 2018

US FDA First's RMAT Designation: Humacyte Got A 'Quick Response'

Mar 26 2017

New funding to take Vital's liver failure cell therapy through Phase III

Sep 28 2012

Related Companies

RedHill Biopharma Ltd.

Humacyte, Inc.

Aimmune Therapeutics, Inc.

Zealand Pharma A/S

Xeris Biopharma Holdings, Inc.

GenSight Biologics S.A.

Vital Therapies, Inc.

Tonix Pharmaceuticals Holding Corp.

Kiora Pharmaceuticals, Inc.

Eli Lilly and Company

Additional Topics

Clinical Trials Research & Development Gastrointestinal Renal Metabolic Disorders Ophthalmic Neurology Liver & Hepatic BioPharmaceutical

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window